Renal vasculitis: microscopic polyarteritis and Wegener's granuloma

Area of Science:

• Nephrology
• Rheumatology
• Immunology

Background:

• Prognosis for kidney small vessel vasculitis has improved significantly over 30 years.
• Despite advances, significant challenges and mortality risks persist, particularly in elderly and frail patients.

Purpose of the Study:

• To evaluate the ongoing challenges and long-term outcomes in patients with kidney small vessel vasculitis.
• To assess the impact of immunosuppressive therapy on survival and complications.

Main Methods:

• Retrospective analysis of patient series.
• Review of treatment regimens, including immunosuppression intensity and specific agents like azathioprine.
• Evaluation of mortality causes, including treatment-related deaths and extrarenal complications.

Main Results:

• While immediate survival has improved with more intense immunosuppression, a notable percentage of deaths (31%) were directly related to these treatments.
• Extrarenal complications, especially in the gastrointestinal tract, can still cause early mortality.
• Long-term, modest immunosuppression appeared to be associated with a low rate of vasculitis relapse.

Conclusions:

• Intensified immunosuppression improves immediate survival but increases mortality risk in elderly patients.
• The optimal duration, agent, and intensity of long-term immunosuppression require further investigation.
• Azathioprine may be a viable alternative to cyclophosphamide, avoiding risks associated with long-term oral cyclophosphamide in this population.